Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc (JAZZ), sold 6,000 shares at $130.00 ($772K) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($772k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $127.23 | 3,000 | $382K | 49.5% |
| 2 | $130.00 | 3,000 | $390K | 50.5% |
| Total | $128.62 avg | 6,000 | $772K | 100% |
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |